Satoh et al. found that after exposure to the carcinogen urethan, Nrf2-deficient mice have a relative increase in the number of tumor foci after 8 weeks of treatment, but by 16 weeks of treatment, these same animals show less advanced malignancy [76]. This evidence concerns the gene NFE2L2 and neoplasm.